Medical technology company Masimo has announced the limited market launch of Sepsis Index (Si), an early warning indicator.

Clinicians can use the early warning indicator to detect possible sepsis in patients being remotely monitored using Masimo Patient SafetyNet, a patient monitoring and surveillance system.

Patient SafetyNet combines real-time physiological data from Masimo and third-party bedside monitoring equipment to create displays that are shown at central stations and help clinicians monitor patients’ conditions from afar.

Si works by quantifying patient status in an easily interpretable sepsis risk score by continuously analysing data of different vital signs and other clinical measurements combined with electronic medical records (EMR) data captured by Patient SafetyNet.

Using the aggregated data from Patient SafetyNet, Si will offer early warning of possible sepsis or other causes of deterioration in a patient’s condition.

It will enable the tracking of patient status following sepsis diagnosis and monitor the effectiveness of treatment and interventions.

Si will also show on-screen decision support and recommended actions, which can be updated by each institution according to its sepsis policy.

The Si algorithm, which can be customised, draws upon the company’s expertise in developing different early-warning risk-scoring solutions, such as Halo and Halo ION.

Masimo founder and CEO Joe Kiani said: “Masimo has always sought to solve those ‘unsolvable’ problems that need resolution.

“Detection of sepsis has long been one of the unsolved clinical problems, and one which we have spent considerable time and effort to remedy. With Sepsis Index, we hope to help doctors and nurses everywhere identify sepsis before it’s too late to treat it.”

At the start of the month, Masimo reported data from a new study of its SpHb on blood transfusion management for adults undergoing major surgery.